You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Antibody in asthma treatment - and explain in detail?
Omalizumab is a blocking antibody that neutralises circulating IgE without binding to cell-bound IgE ,and ,thus inhibits IgE mediated reactions in asthma.Patients should be given a 3 to 4 month trial of therapy to show objective benefit.Omalizumab is usually given as a subcutaneous injection every 2-4 weeks and appears not to have significant side effects,although anaphylaxis is very occasionally seen. Reference:Harrison's medicine-18th edition,page no:2112.